ArticleBMC women's health2025
The intersection of domestic abuse and menopause: a scoping review.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe interplay between menopause and domestic abuse (DA) presents a complex, under-researched nexus within women's health. Menopause, a significant physiological and psychosocial transition, may be affected by, or contribute to, women's experiences of abuse. This scoping review explores how DA during the perimenopausal and postmenopausal stages, referred to as midlife (ages 40-65) impacts symptom severity, abuse dynamics, and healthcare engagement.
methodsA scoping review methodology following the JBI Manual for Evidence Synthesis and PRISMA-ScR guidelines. MEDLINE, CINAHL, Web of Science, and EMBASE were searched for English-language peer-reviewed studies exploring the relationship between menopause and DA with no restriction on date range. Inclusion criteria were studies involving women who were perimenopausal or postmenopausal and had experienced DA.
resultsOf 189 unique records screened, 39 studies were included. Cross-sectional studies were most prevalent (n = 16, 41%), followed by cohort studies (n = 9, 23%) qualitative studies (n = 5, 15%) secondary data analysis (n = 3, 8%) and longitudinal studies (n = 2, 5%). There was also one each (n = 1, 2%) of clinical trial, retrospective analysis, case control study and systematic review. Three interconnected themes were identified:(1) a consistent link between experiences of DA and increased severity of menopausal symptoms (n = 34); (2) a tendency for DA to escalate or (re)emerge during midlife and menopause (n = 5); and (3) missed opportunities for DA disclosure within menopause-related healthcare encounters (n = 14). Studies spanned 14 countries, with the majority conducted in the United States (n = 16). No studies from the UK were identified.
conclusionFor DA survivors there is an increase in menopausal symptoms, with profound effects on their mental, emotional, and physical health. Menopause represents both a potential risk period for DA and an opportunity for healthcare providers to identify abuse. This review highlights the urgent need for trauma-informed, menopause-sensitive healthcare practices, as well as further UK-based research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.